Gene · 3609
ILF3: interleukin enhancer binding factor 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ILF3: interleukin enhancer binding factor 3. Genes, record 3609. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3609
On this page
Gene
- Aliases
- CBTF, DRBF, DRBP76, MMP4, MPHOSPH4, MPP4, MPP4110, NF-AT-90, NF110, NF110b, NF90, NF90a, NF90b, NF90c, NF90ctv, NFAR, NFAR-1, NFAR-2, NFAR110, NFAR2, NFAR90, TCP110, TCP80
- NCBI Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q12906 | Interleukin enhancer-binding factor 3 | 894 | 4 | Ensembl, GeneID, HGNC |
Source UniProt
Patents33
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 17792 | Q12906 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 22035 | Q12906 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 22035 | Q12906 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 17792 | Q12906 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 41697 | Q12906 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 144668 | Q12906 | Espacenet |
| US 9878056 B2 | 2018-01-30 | 1400 | Q12906 | Espacenet |
| US 9874572 B2 | 2018-01-23 | 185 | Q12906 | Espacenet |
| EP 3242136 A2 | 2017-11-08 | 185 | Q12906 | Espacenet |
| JP 2017141230 A | 2017-08-17 | 5468 | Q12906 | Espacenet |
1 to 10 of 33
See all 33 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,314
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ILF3 papers | Newest fiscal year |
|---|---|---|---|
| ZIAAG000511 | Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis | 17 | 2025 |
| ZIAAG000393 | Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging | 11 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 6 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| R01DK057819 | Intestinal Mucosal Growth in Health and Surgical Diseases | 5 | 2025 |
| K12CA215110 | YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM | 4 | 2025 |
| P01CA100730 | Retrovirus Models of Cancer | 3 | 2025 |
| P30AI027763 | UCSF-Bay Area Center for AIDS Research | 3 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,314Source NIH's project files
See all 1,314 nih grantsPapers2,183
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HO-1 Nuclear Interactome Implications in Neuroendocrine Transdifferentiation in Prostate Cancer. | Int J Mol Sci | 2026 | 42737536 | PubTator, text mining | PubMed |
| [Small RNAs and ILF3 protein at the core of the coupling between aberrant mRNA decay and transcriptional adaptation]. | Med Sci (Paris) | 2026 | 42735340 | PubTator, text mining | PubMed |
| ILF3 regulates erythroid differentiation: A single-cell transcriptomic analysis and cellular experiment. | PLoS One | 2026 | 42691027 | PubTator, text mining | PubMed |
| Expression Levels of DNMT1, HDAC1, and MT1E Genes as Diagnostic Biomarkers for Breast Cancer Clinicopathological Features: In Vitro and In Silico Analyses. | Anal Cell Pathol (Amst) | 2026 | 42478333 | PubTator, text mining | PubMed |
| ILF3 promotes proliferation and invasion of hepatocellular carcinoma cells through STAT3 phosphorylation and formation of an endogenous complex with SRPK1. | Cell Signal | 2026 | 42392287 | PubTator, text mining | PubMed |
| Epigenetic regulation of cardiac physiology and pathophysiology: biological sex matters. | J Cardiovasc Aging | 2026 | 42369572 | PubTator, text mining | PubMed |
| YBX1 takes actions on triggering M2-like polarization of macrophages and stabilizing CXCL8 mRNA to exhibit its metastatic potential in bladder cancer. | Int Immunopharmacol | 2026 | 42224999 | PubTator, text mining | PubMed |
| An integrative meta-analysis of SARS-CoV-2 RNA-protein interactomes identifies conserved host factors shared with other RNA viruses. | Brief Funct Genomics | 2026 | 42149692 | PubTator, text mining | PubMed |
| Functionality versus Adaptation: Insights from Transcriptional Adaptation. | J Mol Evol | 2026 | 42133046 | PubTator, text mining | PubMed |
| ILF3 Regulates Cell Proliferation and Metastasis by Competitively Antagonizing the Interaction Between HMGCL and USP38 in Hepatocellular Carcinoma. | Hum Mutat | 2026 | 42063616 | PubTator, text mining | PubMed |
1 to 10 of 2,183
See all 2,183 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3609
GET https://conductscience.org/api/genes/v1/3609/patents?page=2